Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Bon Health vs NovoCare Pharmacy

Bon Health
Graded #93

Higher grade

vs+16.200000000000003
NovoCare Pharmacy
Graded #442

Lower grade

The verdict

Bon Health takes it — 71.4/100 to 55.2/100.

Bon Health grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Bon Health is a physician-led GLP-1 weight-loss telehealth service offering compounded semaglutide and tirzepatide on transparent commitment tiers — from $170/mo on the annual plan up to $330 month-to-month…

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueBon Health +34
58
24
Dose & formulationBon Health +11
77
66
Clinical oversightBon Health +11
85
74
Labs & monitoringBon Health +14
65
51
FulfillmentBon Health +12
88
76
Contract termsNovoCare Pharmacy +2
53
55
Bon Health · left barNovoCare Pharmacy · right bar

The numbers

MetricBon HealthNovoCare Pharmacy
WeighScore71.4/10055.2/100
GradeCC
Scorecard rank#93#442
Semaglutide$170/mo (annual plan, compounded)$349/mo (2.4 mg dose, brand-name)
Tirzepatide$170/mo (annual plan, compounded)Not disclosed
CoverageAll 50 statesAll 50 states
Brand-name accessYesYes
Oral / sublingualInjection onlyYes
Bon Health

Graded #93 · C

Strengths

  • Transparent commitment-tier pricing from $170/mo (annual) for compounded semaglutide and tirzepatide; $0 membership fee, cancel anytime
  • Physician-led: comprehensive medical review and physician-titrated dosing, not a 2-minute quiz
  • 24/7 physician support included free with your order; 1-3 day rapid dispatch
  • Licensed in all 50 states; uses 503A & 503B compounding pharmacies; brand-name Wegovy/Ozempic/Zepbound/Mounjaro also offered

Where it loses points

  • Best rates require a 6- or 12-month commitment ($170-195/mo); month-to-month is $330/mo
  • Doesn't name its specific compounding pharmacy
  • No legal entity name or LegitScript certification shown on the site
  • Compounded GLP-1s are not FDA-approved (the site discloses this)
NovoCare Pharmacy

Graded #442 · C

Strengths

  • First-party Novo Nordisk pharmacy — the most authoritative branded Wegovy channel
  • $199/mo intro pricing on Wegovy 0.25/0.5 mg starter doses (through 6/30/2026), the lowest brand self-pay price
  • $349/mo standard self-pay is well below the ~$1,300/mo retail list price
  • Ships to all 50 states with no telehealth-platform middleman fees
  • Cold-chain logistics handled directly by Novo Nordisk

Where it loses points

  • Wegovy only — no Ozempic, no tirzepatide, no compounded GLP-1
  • Requires an existing Wegovy prescription — no prescribing clinicians or telehealth intake
  • No clinical support included — your own prescriber handles titration and side effects
  • Manufacturer-set pricing can change at any time
  • $199 pen intro covers only the first 2 fills for new patients (through 6/30/2026); maintenance doses are $349/mo ($399 HD)

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard